Complex formation between heptakis(2,6-di-O-methyl)-β-cyclodextrin and cyclopentadienyl molybdenum(II) dicarbonyl complexes: Structural studies and cytotoxicity evaluations

Organometallics

Volumn 27, Issue 19, 2008, Pages 4948-4956

  Pereira, Cláudia C L ^a   Diogo, Cátia V ^b   Burgeiro, Ana ^b   Oliveira, Paulo J ^b   Marques, Maria Paula M ^c   Braga, Susana S ^a   Almeida Paz, Filipe A ^a   Pillinger, Martyn ^a   Gonçalves, Isabel S ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; CYTOTOXICITY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GRAVIMETRIC ANALYSIS; MODEL STRUCTURES; MOLYBDENUM; NUCLEAR MAGNETIC RESONANCE; ORGANOMETALLICS; POWDERS; SOLUTIONS; STRUCTURAL OPTIMIZATION; THERMOGRAVIMETRIC ANALYSIS; X RAY ANALYSIS; X RAY DIFFRACTION ANALYSIS;

AMORPHOUS; AQUEOUS SOLUTIONS; CHEMOTHERAPEUTIC AGENTS; COMPLEX FORMATIONS; CRYSTAL PACKINGS; CYCLOPENTADIENYL; EPIFLUORESCENCE MICROSCOPIES; FTIR SPECTROSCOPIES; IN CELLS; INCLUSION COMPOUNDS; INTERMOLECULAR VOIDS; MELANOMA CELLS; MICROCRYSTALLINE PRODUCTS; MONTE CARLO OPTIMIZATIONS; MYOBLAST CELLS; NONAQUEOUS SOLUTIONS; ORGANOMETALLIC COMPLEXES; ORTHORHOMBIC CRYSTAL SYSTEMS; POWDER XRD; SOLID STATES; SPACE GROUPS; STRUCTURAL MODELS; STRUCTURAL STUDIES; TETRAFLUOROBORATE COMPLEXES; TIME POINTS; UNIT CELLS; X-RAY DIFFRACTIONS;

MOLYBDENUM COMPOUNDS;

EID: 54249115357     PISSN: 02767333     EISSN: None     Source Type: Journal    
DOI: 10.1021/om800413w     Document Type: Article

References (82)

1. Kosenberg, B.; Van Camp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385.
2. Fricker, S. P. Dalton Trans. 2007, 4903.
3. Ott, I.; Gust, R. Arch. Pharm. Chem. Life Sci. 2007, 340, 117.
4. Bergamo, A.; Sava, G. Dalton Trans. 2007, 1267.
5. Ang, W. H.; Dyson, P. J. Eur. J. Inorg. Chem. 2006, 4003.
6. (a) Yan, Y. K.; Melchart, M.; Habtemariam, A.; Sadler, P. J. Chem. Commun. 2005, 4764.
7. (b) Allardyce, C. S.; Dorcier, A.; Scolaro, C.; Dyson, P. J. Appl. Organomet. Chem. 2005, 19, 1.
8. (c) Dyson, P. J.; Sava, G. Dalton Trans. 2006, 1929.
9. (a) Köpf-Maier, P.; Köpf, H. Chem. Rev. 1987, 87, 1137.
10. (b) Köpf-Maier, P. Eur. J. Clin. Pharmacol 1994, 47, 1.
11. (a) Kröger, N.; Kleeberg, U. R.; Mross, K.; Edler, L.; Hossfeld, D. K. Onkologie 2000, 23, 60.
12. (b) Mross, K.; Robben-Bathe, P.; Edler, L.; Baumgart, J.; Berdel, W. E.; Fiebig, H.; Unger, C. Onkologie 2000, 23, 576.
13. (a) Caruso, F.; Rossi, M. Mini-Rev. Med. Chem. 2004, 4, 49.
14. (b) Causey, P. W.; Baird, M. C.; Cole, S. P. C. Organometallics 2004, 23, 4486.
15. (c) Abeysinghe, P. M.; Harding, M. M. Dalton Trans. 2007, 3474.
16. (d) Waern, J. B.; Turner, P.; Harding, M. M. Organometallics 2006, 25, 3417.
17. (e) Vinklárek, J.; Paláĉková, H.; Honziöek, J.; Holubovâ, J.; Holčapek, M.; Cí safová, I. Inorg. Chem. 2006, 45, 2156.
18. (f) Harding, M. M.; Prodigalidad, M.; Lynch, M. J. J. Med. Chem. 1996, 39, 5012.
19. (a) Vessières, A.; Top, S.; Beck, W.; Hillard, E.; Jaouen, G. Dalton Trans. 2006, 529.
20. (b) Nguyen, A.; Marsaud, V.; Bouclier, C.; Top, S.; Vessieres, A.; Pigeon, P.; Gref, R.; Legrand, P.; Jaouen, G.; Renoir, J.-M. Int. J. Pharm. 2008, 347, 128.
21. (a) Alston, D. R.; Lilley, T. H.; Stoddart, J. F. J. Chem. Soc., Chem. Commun. 1985, 1600.
22. (b) Alston, D. R.; Slawin, A. M. Z.; Stoddart, J. F.; Williams, D. J. J. Chem. Soc., Chem. Commun. 1985, 1602.
23. (c) Alston, D. R.; Ashton, P. R.; Lilley, T. H.; Stoddart, J. F.; Zarzycki, R.; Slawin, A. M. Z., Williams, D. J. Carbohydr. Res. 1989, 192, 259.
24. (d) Horvath, G.; Premkumar, T.; Boztas, A.; Lee, E.; Jon, S.; Geckeier, K. E. Mol. Pharm. 2008, 5, 358.
25. (e) Turel, I.; Demšar, A.; Košmrlj, J. J. Inclusion Phenom. Macrocyclic Chem. 1999, 35, 595.
26. (f) Vinklärek, J.; Honzîček, J.; Holubová, J. Central Eur. J. Chem 2005, 3, 72.
27. (g) Pereira, C. C. L.; Nolasco, M.; Braga, S. S.; Paz, F. A. A.; Ribeiro-Claro, P.; Pillinger, M.; Gonçalves, I. S. Organometallics 2007, 26, 4220.
28. (h) Morales, A.; Struppe, J.; Meléndez, E. J. Inclusion Phenom. Macrocydic Chem. 2008, 60, 263.
29. (i) Braga, S. S.; Gonçalves, I. S.; Pillinger, M.; Ribeiro-Claro, P.; Teixeira-Dias, J. J. C. J. Organomet. Chem. 2001, 632, 11.
30. (a) Wheate, N. J.; Buck, D. P.; Day, A. I.; Collins, J. G. Dalton Trans. 2006, 451.
31. (b) Buck, D. P.; Abeysinghe, P. M.; Cullinane, C.; Day, A. I.; Collins, J. G.; Harding, M. M. Dalton Trans. 2008, 2328.
32. (a) Singh, M.; Sharma, R.; Banerjee, U. C. Biotechnol. Adv. 2002, 20, 341.
33. (b) Davis, M. E.; Brewster, M. E. Nat. Rev. Drug Discovery 2004, 3, 1023.
34. (c) Challa, R.; Ahuja, A.; Ali, J.; Khar, R. K. AAPS PharmSciTech 2005, 6, E329.
35. (d) Uekama, K.; Hirayama, F.; Arima, H. J. Inclusion Phenom. Macrocyclic Chem. 2006, 56, 3.
36. Hapiot, F.; Tilloy, S.; Monflier, E. Chem. Rev. 2006, 106, 767.
37. Utsuki, T.; Brem, H.; Pitha, J.; Loftsson, T.; Kristmundsdottir, T.; Tyler, B. M.; Olivi, A. J. Controlled Release 1996, 40, 251.
38. Braga, S. S.; Marques, M. P. M.; Sousa, J. B.; Pillinger, M.; Teixeira-Dias, J. J. C.; Gonçalves, I. S. J. Organomet. Chem. 2005, 690, 2905.
39. Pereira, C. C. L.; Braga, S. S.; Paz, F. A. A.; Pillinger, M.; Klinowski, J.; Gonçalves, I. S. Eur. J. Inorg. Chem. 2006, 4278.
40. Norton de Matos, M. R. P., Romão, C. C.; Pereira, C. C. L.; Rodrigues, S. S.; Mora, M.; Silva, M. J. P.; Alves, P. M.; Reis, C. A. Compositions comprising organometallic molybdenum compounds for treating cancer. International Patent WO/2005/087783.
41. Szejtli, J. J. Inclusion Phenom. Macrocyclic Chem. 1992, 14, 25.
42. Saenger, W. Angew. Chem., Int. Ed. Engl. 1980, 19, 344.
43. (a) Braga, S. S.; Paz, F. A. A.; Pillinger, M.; Seixas, J. D.; Româo, C. C.; Gonçalves, I. S. Eur. J. Inorg. Chem. 2006, 1662.
44. (b) Fernandas, J. A.; Lima, S.; Braga, S. S.; Ribeiro-Claro, P.; Rodriguez-Borges, J. E.; Teixeira, C.; Pillinger, M.; Teixeira-Dias, J. J. C.; Goncalves, I. S. J. Organomet. Chem. 2005, 690, 4801.
45. (c) Petrovski, Z.; Braga, S. S.; Santos, A. M.; Rodrigues, S. S.; Gonçalves, I. S.; Pillinger, M.; Kühn, F. E.; Romão, C. C. Inorg. Chim. Acta 2005, 358, 981.
46. Caira, M. R. Rev. Roumaine Chim. 2001, 46, 371.
47. (a) Allen, F. H. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 380.
48. (b) Allen, F. H.; Motherwell, W. D. S. Acta Crystallogr., Sect. B: Struct. Sci. 2002, 58, 407.
49. DIMEB inclusion compounds have the CSD refcodes BOYGAX, COFLOY, DEZMIE10, DEZMOK10, NITSIS, PABNEM, QAZYEV, QAZYIZ, SAJPOI, WAGHAN01, and YAPSEN10 and can be found in the following references:(a) Tsorteki, F.; Mentzafos, D. Carbohydr. Res. 2002, 337, 1229.
50. (b) Harata, K. Chem. Commun. 1999, 191.
51. (c) Armspach, D.; Ashton, P. R.; Ballardini, R.; Balzani, V.; Godi, A.; Moore, C. P.; Prodi, L.; Spencer, N.; Stoddart, J. F.; Tolley, M. S.; Wear, T. J.; Williams, D. J. Chem.-Eur. J. 1995, 1, 33.
52. (d) Harata, K.; Hirayama, F.; Uekama, K.; Tsoucaris, G. Chem. Lett. 1988, 1585.
53. (e) Harata, K. Bull. Chem. Soc. Jpn. 1988, 62, 1939.
54. (f) Pohlmann, H.; Gdaniec, M.; Eckle, E.; Geiger, G.; Stezowski, J. J. Acta Crystallogr., Sect. A: Found. Crystallogr. 1984, 40, C276.
55. (a) Rodriguez-Carvajal, J. FULLPROF-A Program for Rietveld Refinement and Pattern Matching Analysis. Abstract of the Satellite Meeting on Powder Diffraction of the XV Congress of the IUCR; Toulouse, France, 1990; p 127.
56. (b) Roisnel, T., Rodriguez-Carvajal, J. WinPLOTR [June 2005] - A Windows Tool for Powder Diffraction Pattern Analysis. Proceedings of the Seventh European Powder Diffraction Conference (EPDIC 7), Mater. Sci. Forum; 2001; Vols. 378-381, pp 118-123.
57. Boultif, A.; Louer, D. J. Appl. Crystallogr. 2004, 37, 724.
58. (a) Boultif, A.; Louer, D. J. Appl. Crystallogr. 1991, 24, 987.
59. (b) Louer, D. In Automatic Indexing: Procedures and Applications, Accuracy in Powder Diffraction II; Gaithersburg, MD, 1992; pp 92-104.
60. Laugier, J., Bochu, B. CHECKCELL - A Software Performing Automatic Cell/Space Group Determination; Collaborative Computational Project Number 14 (CCP14); Laboratoire des Matériaux et du Génie Physique de l'Ecole Supérieure de Physique de Grenoble (INPG): France, 2000.
61. LeBail, A.; Duroy, H.; Fourquet, J. L. Mater. Res. Bull. 1988, 23, 447.
62. (a) Favre-Nicolin, V.; Cerný, R. J. Appl. Crystallogr. 2002, 35, 734.
63. (b) Favre-Nicolin, V., Cerný, R. FOX - A Program for ab Initio Structure Solution from Powder Diffraction Data; Program Developed for the Swiss National Science Foundation; University of Geneva: Geneva, Switzerland, 2000.
64. Walters, P.; Stahl, M. BABEL Version 1.3-A Program for the Interconversion of File Formats Used in Molecular Modelling; Department of Chemistry, University of Arizona: Tucson, AZ, 1996.
65. Selkti, M.; Navaza, A.; Villain, F.; Charpin, P.; De Rango, C. J. Inclusion Phenom. Macrocyclic Chem. 1997, 27, 1.
66. (a) March, A. Z. Kristallogr. 1932, 81, 285.
67. (b) Dollase, W. A. J. Appl. Crystallogr. 1986, 19, 267.
68. Takashimi, Y.; Sakamoto, K.; Oizumi, Y.; Yamaguchi, H.; Kamitori, S.; Harada, A. J. Inclusion Phenom. Macrocyclic Chem. 2006, 56, 45.
69. Repesh, L. A. Invasion Metastasis 1989, 9, 192.
70. Pereira, G. C.; Branco, A. F.; Matos, J. A.; Pereira, S. L.; Parke, D.; Perkins, E. L.; Serafim, T. L.; Sardäo, V. A.; Santos, M. S.; Moreno, A. J.; Holy, J.; Oliveira, P. J. J. Phamacol. Exp. Ther. 2007, 323, 636.
71. Serafim, T. L.; Oliveira, P. J.; Sardäo, V. A.; Perkins, E.; Parke, D.; Holy, J. Cancer Chemother, Phamacol. 2008, 61, 1007.
72. Turakhia, S.; Venkatakrishnan, C. D.; Dunsmore, K.; Wong, H.; Kuppusamy, P.; Zweier, J. L.; Ilangovan, G. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3111.
73. Reeve, J. L.; Szegezdi, E.; Logue, S. E.; Chonghaile, T. N.; O'Brien, T.; Ritter, T.; Samali, A. J. Cell. Mol. Med. 2007, 11, 509.
74. Balula, S. S.; Coelho, A. C.; Braga, S. S.; Hazell, A.; Valente, A. A.; Pillinger, M.; Seixas, J. D.; Romão, C. C.; Gonçalves, I. S. Organometallics 2007, 26, 6857.
75. (a) Lichtenthaler, F. W.; Immel, S. Starch/Stärke 1996, 48, 145.
76. (b) Immel, S.; Lichtenthaler, F. W. Starch/Stärke 1996, 48, 225.
77. Loftsson, T.; Másson, M.; Brewster, M. E. J. Pharm. Sci. 2004, 93, 1091.
78. Upadhyay, A. K.; Singh, S.; Chhipa, R. R.; Vijayakumar, M. V.; Ajay, A. K.; Bhat, M. K. Toxicol. Appl. Pharmacol. 2006, 216, 177.
79. Drew, M. G. B.; Félix, V.; Gonçalves, I. S.; Kühn, F. E.; Lopes, A. D.; Româo, C. C. Polyhedron 1998, 17, 1091.
80. Kimes, B. W.; Brandt, B. L. Exp. Cell Res. 1976, 98, 367.
81. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahan, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenny, S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107.
82. Holy, J.; Lamont, G.; Perkins, E. BMC Cell Biol. 2006, 7, 13.